ArticleCell death and differentiation2026

Dual targeting of chemoresistance and ferroptosis in gastric cancer: DDR1/VEGFR2 inhibitor K-13 synergizes with docetaxel from preclinical models to phase Ib/II clinical trial.

Gaoshaer Yeerkenbieke et al.PubMed ↗Publisher ↗

No numbers read from the abstract.